Last reviewed · How we verify
P-Tabletten weiß
At a glance
| Generic name | P-Tabletten weiß |
|---|---|
| Sponsor | Pascoe Pharmazeutische Praeparate GmbH |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects (PHASE2)
- Pharmacological Effects of Neurapas® Balance and Pascoflair® 425 mg on Brain Activity in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- P-Tabletten weiß CI brief — competitive landscape report
- P-Tabletten weiß updates RSS · CI watch RSS
- Pascoe Pharmazeutische Praeparate GmbH portfolio CI